Breaking News Instant updates and real-time market news.

MAR

Marriott

/

+

07:26
02/22/21
02/22
07:26
02/22/21
07:26

Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform

As previously reported, Evercore ISI analyst Rich Hightower upgraded Marriott to Outperform from In Line with a price target of $158, up from $150, as he updated his models for lodging C-Corps following earnings last week from the group. While hotel stocks in general have benefited significantly from the "re-opening trade" over the past 90 or so days, Marriott shares have lagged direct peers over the past 30, 90, and 365 days, noted Hightower, who now views the stock as the best "value play" within his lodging coverage in terms of both REITs and C-Corps.

MAR Marriott
/

+

02/22/21 Evercore ISI
Marriott upgraded to Outperform from In Line at Evercore ISI
02/19/21 Deutsche Bank
Marriott price target raised to $135 from $96 at Deutsche Bank
01/05/21 Gordon Haskett
Marriott price target raised to $125 from $108 at Gordon Haskett
12/15/20 Citi
Marriott upgraded to Buy from Neutral at Citi

TODAY'S FREE FLY STORIES

Recommendations
ChemoCentryx price target raised to $101 from $83 at H.C. Wainwright » 06:15
03/02/21
03/02
06:15
03/02/21
06:15
CCXI

ChemoCentryx

$68.79 /

+0.89 (+1.31%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCXI ChemoCentryx
$68.79 /

+0.89 (+1.31%)

CCXI ChemoCentryx
$68.79 /

+0.89 (+1.31%)

03/01/21 Stifel
ChemoCentryx initiated with a Buy at Stifel
12/22/20 Piper Sandler
Piper names ChemoCentryx a top pick for 2021, boosts target to $80
11/03/20 Piper Sandler
Piper confident in U.S. and EU approvals for ChemoCentryx's avacopan
10/29/20
Fly Intel: Top five analyst downgrades
CCXI ChemoCentryx
$68.79 /

+0.89 (+1.31%)

  • 11
    Jun
CCXI ChemoCentryx
$68.79 /

+0.89 (+1.31%)

Downgrade
Athenex downgraded to Perform from Outperform at Oppenheimer » 06:14
03/02/21
03/02
06:14
03/02/21
06:14
ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

Oppenheimer downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

05:37 Today Truist
Athenex downgraded to Hold from Buy at Truist
03/01/21 JPMorgan
JPMorgan downgrades Athenex on 'huge surprise' from FDA
03/01/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/01/21 JPMorgan
Athenex downgraded to Neutral from Overweight at JPMorgan
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

  • 10
    Sep
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

Hot Stocks
CareTrust REIT acquires four California CCRCs in Southern California » 06:13
03/02/21
03/02
06:13
03/02/21
06:13
CTRE

CareTrust REIT

$22.82 /

+0.59 (+2.65%)

, MAR

Marriott

$148.22 /

+0.11 (+0.07%)

CareTrust REIT (CTRE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTRE CareTrust REIT
$22.82 /

+0.59 (+2.65%)

MAR Marriott
$148.22 /

+0.11 (+0.07%)

CTRE CareTrust REIT
$22.82 /

+0.59 (+2.65%)

01/19/21 Barclays
CareTrust REIT price target raised to $25 from $21 at Barclays
01/13/21 Mizuho
CareTrust REIT price target raised to $22 from $19 at Mizuho
01/07/21 BMO Capital
CareTrust REIT upgraded to Outperform from Market Perform at BMO Capital
12/14/20 KeyBanc
CareTrust REIT upgraded to Overweight from Sector Weight at KeyBanc
MAR Marriott
$148.22 /

+0.11 (+0.07%)

02/24/21 Stifel
American Airlines price target raised to $20 from $14 at Stifel
02/22/21 Wells Fargo
Marriott price target raised to $154 from $147 at Wells Fargo
02/22/21 Wells Fargo
Wells Fargo strategist upgrades Consumer Services sector to Overweight
02/22/21 Evercore ISI
Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform
CTRE CareTrust REIT
$22.82 /

+0.59 (+2.65%)

MAR Marriott
$148.22 /

+0.11 (+0.07%)

MAR Marriott
$148.22 /

+0.11 (+0.07%)

MAR Marriott
$148.22 /

+0.11 (+0.07%)

MAR Marriott
$148.22 /

+0.11 (+0.07%)

Recommendations
Chiasma price target raised to $12 from $10 at H.C. Wainwright » 06:13
03/02/21
03/02
06:13
03/02/21
06:13
CHMA

Chiasma

$3.95 /

+0.055 (+1.41%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHMA Chiasma
$3.95 /

+0.055 (+1.41%)

CHMA Chiasma
$3.95 /

+0.055 (+1.41%)

01/11/21 Piper Sandler
Chiasma price target lowered to $15 from $19 at Piper Sandler
11/05/20 Piper Sandler
Chiasma reports first Mycapssa sales, strong cash balance, says Piper Sandler
08/31/20 Piper Sandler
Piper sees strong demand for Chiasma's oral acromegaly therapy
08/13/20 Jefferies
Chiasma initiated with a Buy at Jefferies
CHMA Chiasma
$3.95 /

+0.055 (+1.41%)

  • 01
    Jul
Recommendations
Procter & Gamble removed from the US 1 List at BofA  06:12
03/02/21
03/02
06:12
03/02/21
06:12
PG

Procter & Gamble

$124.25 /

+0.75 (+0.61%)

 
ShowHide Related Items >><<
PG Procter & Gamble
$124.25 /

+0.75 (+0.61%)

PG Procter & Gamble
$124.25 /

+0.75 (+0.61%)

01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
01/19/21 Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
01/13/21 Deutsche Bank
Procter & Gamble price target raised to $159 from $156 at Deutsche Bank
PG Procter & Gamble
$124.25 /

+0.75 (+0.61%)

PG Procter & Gamble
$124.25 /

+0.75 (+0.61%)

PG Procter & Gamble
$124.25 /

+0.75 (+0.61%)

PG Procter & Gamble
$124.25 /

+0.75 (+0.61%)

Periodicals
Tailored Brands nears $75M loan after bankruptcy exit, WSJ reports » 06:12
03/02/21
03/02
06:12
03/02/21
06:12
TLRD

Tailored Brands

$0.00 /

+ (+0.00%)

Tailored Brands Inc., the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TLRD Tailored Brands
$0.00 /

+ (+0.00%)

TLRD Tailored Brands
$0.00 /

+ (+0.00%)

03/19/20 Deutsche Bank
Tailored Brands price target lowered to $1 from $4 at Deutsche Bank
Recommendations
Dentsply Sirona price target raised to $60 from $55 at H.C. Wainwright » 06:11
03/02/21
03/02
06:11
03/02/21
06:11
XRAY

Dentsply Sirona

$59.71 /

+6.71 (+12.66%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XRAY Dentsply Sirona
$59.71 /

+6.71 (+12.66%)

XRAY Dentsply Sirona
$59.71 /

+6.71 (+12.66%)

03/01/21 Piper Sandler
Dentsply Sirona price target raised to $70 from $63 at Piper Sandler
02/09/21 Stifel
Dentsply Sirona checks point to potential channel conflict, says Stifel
01/08/21 Credit Suisse
Envista upgraded to Outperform from Neutral at Credit Suisse
01/05/21 Baird
Dentsply Sirona price target raised to $62 from $58 at Baird
XRAY Dentsply Sirona
$59.71 /

+6.71 (+12.66%)

XRAY Dentsply Sirona
$59.71 /

+6.71 (+12.66%)

XRAY Dentsply Sirona
$59.71 /

+6.71 (+12.66%)

Initiation
Darling Ingredients initiated with an Overweight at Piper Sandler » 06:10
03/02/21
03/02
06:10
03/02/21
06:10
DAR

Darling Ingredients

$64.07 /

+1.005 (+1.59%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAR Darling Ingredients
$64.07 /

+1.005 (+1.59%)

DAR Darling Ingredients
$64.07 /

+1.005 (+1.59%)

01/29/21 Baird
Darling Ingredients price target raised to $71 from $50 at Baird
01/27/21 JPMorgan
Darling Ingredients price target raised to $69 from $48 at JPMorgan
11/05/20 BMO Capital
Darling Ingredients price target raised to $46 from $33 at BMO Capital
10/22/20 Roth Capital
Darling Ingredients price target raised to $84 from $38 at Roth Capital
DAR Darling Ingredients
$64.07 /

+1.005 (+1.59%)

Hot Stocks
Kaixin Auto announces Haitaoche's subsidiaries new vehicle sales contracts » 06:10
03/02/21
03/02
06:10
03/02/21
06:10
KXIN

Kaixin Auto

$3.49 /

+0.11 (+3.25%)

Kaixin Auto Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KXIN Kaixin Auto
$3.49 /

+0.11 (+3.25%)

KXIN Kaixin Auto
$3.49 /

+0.11 (+3.25%)

KXIN Kaixin Auto
$3.49 /

+0.11 (+3.25%)

Periodicals
Frontier Airlines cancels flight after passengers refuse to wear masks, NYT says » 06:10
03/02/21
03/02
06:10
03/02/21
06:10
FRNTQ

Frontier Airlines

$0.00 /

+ (+0.00%)

Frontier Airlines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
F5 Networks price target raised to $223 from $216 at Piper Sandler » 06:09
03/02/21
03/02
06:09
03/02/21
06:09
FFIV

F5 Networks

$194.05 /

+3.92 (+2.06%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FFIV F5 Networks
$194.05 /

+3.92 (+2.06%)

FFIV F5 Networks
$194.05 /

+3.92 (+2.06%)

01/27/21 RBC Capital
F5 Networks price target raised to $200 from $182 at RBC Capital
01/27/21 Piper Sandler
F5 Networks price target raised to $216 from $205 at Piper Sandler
01/25/21 Cowen
F5 Networks price target raised to $255 from $223 at Cowen
01/14/21 Barclays
F5 Networks price target raised to $235 from $212 at Barclays
FFIV F5 Networks
$194.05 /

+3.92 (+2.06%)

FFIV F5 Networks
$194.05 /

+3.92 (+2.06%)

FFIV F5 Networks
$194.05 /

+3.92 (+2.06%)

FFIV F5 Networks
$194.05 /

+3.92 (+2.06%)

Hot Stocks
Yatsen to acquire Eve Lom from Manzanita Capital, terms undisclosed » 06:09
03/02/21
03/02
06:09
03/02/21
06:09
YSG

Yatsen

$18.63 /

+1.055 (+6.00%)

Yatsen announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YSG Yatsen
$18.63 /

+1.055 (+6.00%)

YSG Yatsen
$18.63 /

+1.055 (+6.00%)

12/14/20 Morgan Stanley
Yatsen initiated with an Equal Weight at Morgan Stanley
12/13/20 Goldman Sachs
Yatsen initiated with a Neutral at Goldman Sachs
YSG Yatsen
$18.63 /

+1.055 (+6.00%)

  • 19
    Nov
YSG Yatsen
$18.63 /

+1.055 (+6.00%)

YSG Yatsen
$18.63 /

+1.055 (+6.00%)

Upgrade
Hims & Hers upgraded to Buy from Neutral at Citi » 06:09
03/02/21
03/02
06:09
03/02/21
06:09
HIMS

Hims & Hers

$15.26 /

+0.65 (+4.45%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

02/17/21 Citi
Hims & Hers initiated with a Neutral at Citi
02/12/21
Fly Intel: Top five analyst initiations
02/12/21 Piper Sandler
Hims & Hers initiated with a Neutral at Piper Sandler
02/08/21 Tigress Financial
Hims & Hers initiated with a Buy at Tigress Financial
HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

Initiation
Angion Biomedica initiated with an Outperform at Cowen » 06:08
03/02/21
03/02
06:08
03/02/21
06:08
ANGN

Angion Biomedica

$19.85 /

+2.6 (+15.07%)

Cowen analyst Marc Frahm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANGN Angion Biomedica
$19.85 /

+2.6 (+15.07%)

03/01/21 H.C. Wainwright
Angion Biomedica initiated with a Buy at H.C. Wainwright
  • 05
    Feb
ANGN Angion Biomedica
$19.85 /

+2.6 (+15.07%)

Recommendations
Splunk may see 'slight upside' in Q4 results, says RBC Capital » 06:08
03/02/21
03/02
06:08
03/02/21
06:08
SPLK

Splunk

$151.21 /

+8.2 (+5.73%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$151.21 /

+8.2 (+5.73%)

SPLK Splunk
$151.21 /

+8.2 (+5.73%)

02/24/21 Jefferies
Jefferies remains a buyer of Splunk, sees 'favorable set-up' into earnings
02/17/21 Mizuho
Splunk price target raised to $190 from $180 at Mizuho
02/11/21 Oppenheimer
Splunk assumed with an Outperform at Oppenheimer
01/21/21 Goldman Sachs
Splunk assumed with a Buy at Goldman Sachs
SPLK Splunk
$151.21 /

+8.2 (+5.73%)

SPLK Splunk
$151.21 /

+8.2 (+5.73%)

SPLK Splunk
$151.21 /

+8.2 (+5.73%)

SPLK Splunk
$151.21 /

+8.2 (+5.73%)

Hot Stocks
Axonics enters strategic alliance with Micro Systems Technologies » 06:07
03/02/21
03/02
06:07
03/02/21
06:07
AXNX

Axonics

$53.37 /

+2.98 (+5.91%)

Axonics announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$53.37 /

+2.98 (+5.91%)

AXNX Axonics
$53.37 /

+2.98 (+5.91%)

01/26/21 Baird
Axonics price target raised to $65 from $58 at Baird
01/26/21 Piper Sandler
Axonics price target raised to $64 from $57 at Piper Sandler
01/07/21 Morgan Stanley
Axonics price target raised to $58 from $53 at Morgan Stanley
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
AXNX Axonics
$53.37 /

+2.98 (+5.91%)

  • 08
    May
AXNX Axonics
$53.37 /

+2.98 (+5.91%)

Upgrade
Enable Midstream upgraded to Equal Weight from Underweight at Barclays » 06:07
03/02/21
03/02
06:07
03/02/21
06:07
ENBL

Enable Midstream

$6.85 /

+0.25 (+3.79%)

, ET

Energy Transfer LP

$8.13 /

+0.5 (+6.55%)

Barclays analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENBL Enable Midstream
$6.85 /

+0.25 (+3.79%)

ET Energy Transfer LP
$8.13 /

+0.5 (+6.55%)

ENBL Enable Midstream
$6.85 /

+0.25 (+3.79%)

03/01/21 Mizuho
Enable Midstream downgraded to Neutral from Buy at Mizuho
11/16/20 Mizuho
OGE Energy downgraded to Neutral on valuation at Mizuho
10/26/20 Mizuho
CenterPoint Energy price target raised to $25 from $20 at Mizuho
10/15/20 Wells Fargo
OGE Energy upgraded to Overweight at Wells Fargo
ET Energy Transfer LP
$8.13 /

+0.5 (+6.55%)

03/01/21 Mizuho
Enable Midstream downgraded to Neutral from Buy at Mizuho
02/25/21 UBS
UBS names Energy Transfer LP to Top Picks, raises price target raised to $16
02/22/21 Piper Sandler
Energy Transfer LP upgraded to Overweight from Neutral at Piper Sandler
01/12/21 Barclays
Energy Transfer LP upgraded to Overweight from Equal Weight at Barclays
ENBL Enable Midstream
$6.85 /

+0.25 (+3.79%)

ET Energy Transfer LP
$8.13 /

+0.5 (+6.55%)

ENBL Enable Midstream
$6.85 /

+0.25 (+3.79%)

ET Energy Transfer LP
$8.13 /

+0.5 (+6.55%)

ET Energy Transfer LP
$8.13 /

+0.5 (+6.55%)

Hot Stocks
McDonald's CEO vows to crack down on sexual harassment in the workplace » 06:07
03/02/21
03/02
06:07
03/02/21
06:07
MCD

McDonald's

$208.25 /

+2.1 (+1.02%)

McDonald's CEO Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCD McDonald's
$208.25 /

+2.1 (+1.02%)

MCD McDonald's
$208.25 /

+2.1 (+1.02%)

02/22/21 Wells Fargo
Wells Fargo strategist upgrades Consumer Services sector to Overweight
02/01/21 Citi
Citi opens 'Catalyst Watch' on McDonald's into chicken sandwich launch
01/21/21 UBS
UBS sees 'golden' risk reward for McDonald's
01/19/21 Goldman Sachs
McDonald's initiated with a Buy at Goldman Sachs
MCD McDonald's
$208.25 /

+2.1 (+1.02%)

MCD McDonald's
$208.25 /

+2.1 (+1.02%)

MCD McDonald's
$208.25 /

+2.1 (+1.02%)

MCD McDonald's
$208.25 /

+2.1 (+1.02%)

Upgrade
Zoom Video upgraded to Overweight from Neutral at Piper Sandler » 06:07
03/02/21
03/02
06:07
03/02/21
06:07
ZM

Zoom Video

$409.67 /

+35.805 (+9.58%)

Piper Sandler analyst…

Piper Sandler analyst James Fish upgraded Zoom Video Communications to Overweight from Neutral with a price target of $541, up from $501. The company reported a "very strong" end to fiscal 2021 and "better than feared" initial fiscal 2022 guidance, with Zoom Phone adoption and continued wins in Meetings both contributing to the upside, Fish tells investors in a research note. The analyst sees "multiple secular tailwinds behind the business."

ShowHide Related Items >><<
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
01/13/21 Stifel
Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
01/13/21 Morgan Stanley
Investors have turned too negative on Zoom's persistence, says Morgan Stanley
12/24/20 DA Davidson
DA Davidson likes Zoom push into email, says buy on recent selloff
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

  • 13
    Jan
ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

ZM Zoom Video
$409.67 /

+35.805 (+9.58%)

Hot Stocks
X Financial to invest $10M in Dragonfly Ventures II VC fund » 06:06
03/02/21
03/02
06:06
03/02/21
06:06
XYF

X Financial

$3.46 /

+0.08 (+2.37%)

X Financial announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XYF X Financial
$3.46 /

+0.08 (+2.37%)

Earnings
KVH Industries reports Q4 non-GAAP EPS 7c, consensus 2c » 06:06
03/02/21
03/02
06:06
03/02/21
06:06
KVHI

KVH Industries

$14.15 /

+0.37 (+2.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KVHI KVH Industries
$14.15 /

+0.37 (+2.69%)

KVHI KVH Industries
$14.15 /

+0.37 (+2.69%)

Hot Stocks
Oyster Point Pharma says FDA accepts NDA for OC-01 (varenicline) nasal spray » 06:06
03/02/21
03/02
06:06
03/02/21
06:06
OYST

Oyster Point Pharma

$19.76 /

-0.07 (-0.35%)

Oyster Point Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OYST Oyster Point Pharma
$19.76 /

-0.07 (-0.35%)

OYST Oyster Point Pharma
$19.76 /

-0.07 (-0.35%)

08/05/20 Piper Sandler
Oyster Point Pharma remains 'fundamentally undervalued,' says Piper Sandler
05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
05/11/20 Piper Sandler
Piper says Oyster Point 'highly likely' to get dry eye approval, superior label
03/30/20 Piper Sandler
Oyster Point ONSET-2 trial barely impacted by COVID-19, says Piper Sandler
OYST Oyster Point Pharma
$19.76 /

-0.07 (-0.35%)

  • 15
    May
Upgrade
Bank of Nova Scotia upgraded to Outperformer from Neutral at CIBC » 06:05
03/02/21
03/02
06:05
03/02/21
06:05
BNS

Bank of Nova Scotia

$59.74 /

+1.365 (+2.34%)

CIBC analyst Paul Holden…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNS Bank of Nova Scotia
$59.74 /

+1.365 (+2.34%)

02/25/21 Desjardins
Bank of Nova Scotia price target raised to C$79 from C$72 at Desjardins
02/24/21 Canaccord
Bank of Nova Scotia price target raised to C$77 from C$70.50 at Canaccord
02/24/21 BMO Capital
Bank of Nova Scotia price target raised to C$80 from C$75 at BMO Capital
02/24/21 National Bank
Bank of Nova Scotia price target raised to C$77 from C$70 at National Bank
Downgrade
Royal Bank of Canada downgraded to Neutral from Buy at BofA » 06:05
03/02/21
03/02
06:05
03/02/21
06:05
RY

Royal Bank of Canada

$86.76 /

+1.67 (+1.96%)

BofA downgraded Royal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RY Royal Bank of Canada
$86.76 /

+1.67 (+1.96%)

RY Royal Bank of Canada
$86.76 /

+1.67 (+1.96%)

03/01/21 Argus
Royal Bank of Canada price target raised to $100 from $92 at Argus
02/26/21 Desjardins
Royal Bank of Canada price target raised to C$119 from C$117 at Desjardins
02/25/21 Canaccord
Royal Bank of Canada price target raised to C$123 from C$116 at Canaccord
02/25/21 BMO Capital
Royal Bank of Canada price target raised to C$120 from C$111 at BMO Capital
RY Royal Bank of Canada
$86.76 /

+1.67 (+1.96%)

Recommendations
Ventas price target raised to $58 from $54 at RBC Capital » 06:05
03/02/21
03/02
06:05
03/02/21
06:05
VTR

Ventas

$52.77 /

-0.17 (-0.32%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTR Ventas
$52.77 /

-0.17 (-0.32%)

VTR Ventas
$52.77 /

-0.17 (-0.32%)

02/09/21 Mizuho
Ventas price target raised to $45 from $38 at Mizuho
01/11/21 BMO Capital
Brookdale data supports cautious view on senior housing, says BMO
01/07/21 BMO Capital
Ventas downgraded to Underperform from Market Perform at BMO Capital
01/05/21 Baird
Healthpeak assumed with an Outperform at Baird
VTR Ventas
$52.77 /

-0.17 (-0.32%)

VTR Ventas
$52.77 /

-0.17 (-0.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.